Investigation of the Safety and Efficacy of JTT-751 in Non-dialysis CKD Patients (Extension Study)
Phase 3
- Conditions
- Chronic Kidney Disease
- Registration Number
- JPRN-jRCT2080221399
- Lead Sponsor
- JAPAN TABACCO INC.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Non-dialysis CKD patients who had completed the preceding double-blind study and who was considered available for continuous administration of investigational drug as judged by the investigator
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety and Efficacy
- Secondary Outcome Measures
Name Time Method